Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06070870 · ClinicalTrials.gov registry record · NA
Health Education Approach to Lung Screening
A NA study of Lung Cancer, sponsored by Virginia Commonwealth University.
- Recruiting
- Registry status
- NA
- Development phase
- 675
- Enrollment target
- 3
- Study locations
NCT06070870: Recruiting NA study of Lung Cancer, sponsored by Virginia Commonwealth University.
NCT06070870 is a NA study of Lung Cancer that is actively recruiting participants, run by Virginia Commonwealth University. The registered enrollment target is 675 participants, below the 934-participant average among 409 other Lung Cancer trials with a reported enrollment target (28% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06070870, a NA study of Lung Cancer, is actively recruiting participants, sponsored by Virginia Commonwealth University.
- RECRUITING
- Registry status
- NA
- Development phase
- 675 participants
- Enrollment target
- 3
- Study locations
Study Summary
Evaluate the impact of the patient navigation program on the proportion of patients who complete lung cancer screening (LCS), defined as undergoing a low dose computed tomography (LDCT)
Primary Outcome
Evaluate the impact of the patient navigation program on the number of patients who complete lung cancer screening (LCS), defined as undergoing a low dose computed tomography (LDCT).
Conditions Studied
Interventions
- BEHAVIORAL Patient Navigation
Study Locations (3)
North Carolina
- University of North Carolina-Chapel Hill - Carrboro
South Carolina
- Medical University of South Carolina - Charleston
Virginia
- Virginia Commonwealth University - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 675 participants |
| Start Date | 2023-10-10 |
| Est. Completion | 2027-04-30 |
| Phase | NA |
What NCT06070870 shows while recruiting
NCT06070870 is an interventional study that assigns participants to a tested intervention. The registered 675 participants enrollment target is mid-sized for trials with a published cap, below the 934-participant average among 409 other Lung Cancer trials with a reported enrollment target (28% lower).
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Patient Navigation is the first listed.
NCT06070870 reports a single indexed study location in North Carolina, South Carolina, Virginia.
Frequently Asked Questions
What is clinical trial NCT06070870 about?
NCT06070870 is a clinical study titled "Health Education Approach to Lung Screening". Evaluate the impact of the patient navigation program on the proportion of patients who complete lung cancer screening (LCS), defined as undergoing a low dose computed tomography (LDCT)
What is the current status of trial NCT06070870?
This trial is currently recruiting. It is a NA study. The enrollment target is 675 participants. The study started on 2023-10-10. Estimated completion is 2027-04-30.
What conditions does trial NCT06070870 study?
This clinical trial studies the following conditions: Lung Cancer.
What interventions are being tested in trial NCT06070870?
The interventions under investigation include: Patient Navigation (BEHAVIORAL).
Who is sponsoring clinical trial NCT06070870?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06070870 being conducted?
This trial has 3 study locations across North Carolina, South Carolina, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06070870's enrollment target sits among peer trials
675 62nd of 409 higher than 348 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
Lung Cancer Screening in High-risk Black Individuals
RECRUITING · NA
-
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
RECRUITING · NA
-
Exercise as Maintenance Therapy in Advanced Lung Cancer
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04788277 · 675 participants
Investigation Into Detection of Prostate Cancer Using Voided Urine (Prostate VPAC)
- NCT05356234 · 675 participants · NA
Ignite Study of the Jewish Family and Children's Service of the Suncoast, Inc.
- NCT06357533 · 675 participants · Phase 3
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
- NCT06461897 · 675 participants · Phase 3
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI